Optimization of qPCR conditions is important for the development of a robust assay. Indications of poor optimization are a lack of reproducibility between replicates as well as inefficient and insensitive assays. The two main approaches are optimization of primer concentration and/or annealing temperatures.
Analysis of gene expression data requires a stable reference or loading control. This reference is usually one or more reference genes. Suitable reference genes are those which are unaffected by differences in samples and experimental treatments and these must be determined for each experimental model. When performing a trial to select stable reference genes it is critical that the genes selected are from different biological pathways and that their expression is independently regulated. Ideally all reference gene candidates are tested on a selection of five test and five control samples.
1. Calculate the number of reactions required for each reference gene. Prepare sufficient mix for two reactions per
sample. For example if testing 5 test and 5 control samples, two No Template Controls (NTC) = 22 reactions. Calculate
sufficient for 10% extra to allow for pipetting error.
2. Prepare qPCR master mix for each Reference Gene primer pair according to Table P15-38. Do not add cDNA to the
master mix. Mix well and avoid bubbles.
3. Add 15 μL of master mix to the defined tubes/wells.
4. Add 5 μL of appropriate template (sample or water for NTC to the defined tubes/wells).
5. Cap tubes or seal plates and label. (Make sure the labeling does not obscure instrument excitation/detection light path.)
6. Run reactions according to the three-step protocol below (Table P15-39). Steps 1–3 are repeated through 40 cycles.
7. Data Analysis to analyze data and determine the most stable reference gene or combination of genes.
Note: Use standard dissociation curve protocol (data collection).
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.